Monoclonal anti-double-stranded DNA antibodies cross-react with phosphoglycerate kinase 1 and inhibit the expression and production of IL-2 in activated Jurkat T cell line

Clinical Immunology

Volumn 120, Issue 3, 2006, Pages 326-334

  Luan, Hui Ying ^a   Tang, Shye Jye ^b   Yang, Winnie ^c   Tsai, Chang Youh ^d   Sun, Guang Huan ^e   Sun, Kuang Hui ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN OCEAN UNIVERSITY   (Taiwan)

^c TAIPEI CITY HOSPITAL   (Taiwan)

^d Immunology and Rheumatology   (Taiwan)

^e TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

Anti double strand DNA antibodies; IL 2; Phosphoglycerate kinase 1; SLE

Indexed keywords

DEOXYRIBONUCLEASE I; DOUBLE STRANDED DNA; DOUBLE STRANDED DNA ANTIBODY; INTERLEUKIN 2; MESSENGER RNA; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 9D7; PHOSPHOGLYCERATE KINASE; PHOSPHOGLYCERATE KINASE 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBODY TITER; ARTICLE; BINDING AFFINITY; CELL ACTIVATION; CONTROLLED STUDY; CROSS REACTION; CYTOKINE PRODUCTION; GENE ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SYSTEMIC LUPUS ERYTHEMATOSUS; THYMUS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ALKALINE PHOSPHATASE; ANIMALS; ANTIBODIES, ANTINUCLEAR; ANTIBODIES, MONOCLONAL; CROSS REACTIONS; CYTOKINES; DNA; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INTERLEUKIN-2; JURKAT CELLS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; PHOSPHOGLYCERATE KINASE; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; T-LYMPHOCYTES; TRANSCRIPTION, GENETIC;

EID: 33746992175     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2006.06.002     Document Type: Article

References (39)

1. Hahn B.H. Antibodies to DNA. N. Engl. J. Med. 338 (1998) 1359-1368
2. Puccetti A., Madaio M.P., and Bellese G. Anti-DNA antibodies bind to DNase I. J. Exp. Med. 181 (1995) 1797-1804
3. Yanase K., Smith R.M., Puccetti A., Jarett L., and Madaio M.P. Receptor-mediated cellular entry of nuclear localizing anti-DNA antibodies via myosin. J. Clin. Invest. 100 (1997) 25-31
4. Seddiki N., Nato F., Lafaye P., Amoura Z., Piette J.C., and Mazié J.C. Calreticulin, a potential cell surface receptor involved in cell penetration of anti-DNA antibodies. J. Immunol. 166 (2001) 6423-6429
5. Giorgio L.A., Konstantinov K.N., Lee S.C., Hardin J.A., Volpe B.T., and Diamond B. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat. Med. 7 (2001) 1189-1193
6. Deocharan B., Qing X., Lichauco J., and Putterman C. α-Actinin is a cross-reactive renal target for pathogenic anti-DNA antibodies. J. Immunol. 168 (2002) 3072-3078
7. Sun K.H., Yu C.L., Tang S.J., and Sun G.H. Monoclonal anti-double-stranded DNA autoantibody stimulates the expression and release of IL-1β, IL-6, IL-8, IL-10 and TNF-α from normal human mononuclear cells involving in the lupus pathogenesis. Immunology 99 (2000) 352-360
8. Avrameas A., Ternynck T., Nato F., Buttin G., and Avrameas S. Polyreactive anti-DNA monoclonal antibodies and a derived peptide as vectors for the intracytoplasmic and intranuclear translocation of macromolecules. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 5601-5606
9. Rahman A. Cytokines in systemic lupus erythematosus. Arthritis Res. Ther. 5 (2003) 160-164
10. Brennan F.M., and Feldmann M. Cytokines in autoimmunity. Curr Opin. Immunol. 8 (1996) 872-877
11. Nicholson L.B., and Kuchroo V.K. Manipulation of the Th1/Th2 balance in autoimmune disease. Curr. Opin. Immunol. 8 (1996) 837-842
12. Lai K.N., Leung J.C.K., Lai K.B., Li P.K.T., and Lai C.K.W. Anti-DNA autoantibodies stimulate the release of IL-1 and IL-6 from endothelial cells. J. Pathol. 178 (1996) 451-457
13. Sun K.H., Tang S.J., Wang Y.S., Lin W.J., and You R.I. Autoantibodies to dsDNA cross-react with the arginine-glycine-rich domain of heterogeneous nuclear ribonucleoprotein A2 (hnRNP A2) and promote methylation of hnRNP A2. Rheumatology 42 (2003) 154-161
14. Amoura Z., Piette J.C., Bach J.F., and Koutouzov S. The key role of nucleosomes in lupus. Arthritis Rheum. 42 (1999) 833-843
15. Tan E.M., Cohen A.S., Fries J.F., Masi A.T., McShane D.J., Rothfield N.F., Schaller J.G., Talal N., and Winchester R.J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25 (1982) 1271-1277
16. Rekvig O.P., and Nossent J.C. Anti-double-stranded DNA antibodies, nucleosomes, and systemic lupus erythematosus. Arthritis Rheum. 48 (2003) 300-312
17. Hurez V., Dietrich G., Kaveri S.V., and Kazatchkine M.D. Ployreactivity is a property of natural and disease-associated human autoantibodies. Scand. J. Immunol. 38 (1993) 190-196
18. Sun K.H., Liu W.T., Tsai C.Y., Tang S.J., Han S.H., and Yu C.L. Anti-dsDNA antibodies cross-react with ribosomal P proteins expressed on the surface of glomerular mesangial cells to exert a cytostatic effect. Immunology 85 (1995) 262-269
19. Reichlin M. Cellular dysfunction induced by penetration of autoantibodies into living cells: cellular damage and dysfunction mediated by antibodies to dsDNA and ribosomal P proteins. J. Autoimmun. 11 (1998) 557-561
20. VandeBerg J.L. The phosphoglycerate kinase isozyme system in mammals: biochemical, genetic, developmental, and evolutionary aspects, Isozymes. Curr. Top. Biol. Med. Res. 12 (1985) 133-187
21. Popanda O., Fox G., and Thielmann H.W. Modulation of DNA polymerases α, δ and ε by lactate dehydrogenase and 3-phosphoglycerate kinase. Biochim. Biophys. Acta 1397 (1998) 102-117
22. Ogino T., Iwama M., Kinouchi J., Shibagaki Y., Tsukamoto T., and Mizumoto K. Involvement of a cellular glycolytic enzyme, phosphoglycerate kinase, in Sendai virus transcription. J. Biol. Chem. 274 (1999) 35999-36008
23. Alloush H.M., Lopez-Ribot J.L., Masten B.J., and Chaffin W.L. 3-Phosphoglycerate kinase: a glycolytic enzyme protein present in the cell wall of Candida albicans. Microbiology 143 (1997) 321-330
24. Lay A.J., Jiang X.M., Kisker O., Flynn E., Underwood A., Condron R., and Hogg P.J. Phosphoglycerate kinase acts in tumor angiogenesis as a disulphide reductase. Nature 408 (2000) 869-873
25. Kraus A.P., Langston Jr. M.F., and Lynch B.L. Red cell phosphoglycerate kinase deficiency. A new cause of non-spherocytic hemolytic anemia. Biochem. Biophys. Res. Commun. 30 (1968) 173-177
26. Rosa R., George C., Fardeau M., Calvin M.C., Rapin M., and Rosa J. A new case of phosphoglycerate kinase deficiency: PGK Creteil associated with rhabdomyolysis and lacking hemolytic anemia. Blood 60 (1982) 84-91
27. Turner G., Fletcher J., Elber J., Yanagawa Y., Dave V., and Yoshida A. Molecular defect of a phosphoglycerate kinase variant associated with hemolytic anemia and neurological disorders in a large kindred. Br. J. Hematol. 91 (1995) 60-65
28. Tsokos G.C., Nambiar M.P., Tenbrock K., and Juang Y.T. Rewiring the T cell: signaling defects and novel prospects for the treatment of SLE. Trends Immunol. 24 (2003) 259-263
29. Llorente L., Richaud-Patin Y., Garcia-Padilla C., Claret E., Jakez-Ocampo J., Cardiel M.H., Alcocer-Varela J., Grangeot-Keros L., Alarcon-Segovia D., Wijdenes J., Galanaud P., and Emilie D. Clinical and biological effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus. Arthritis Rheum. 43 (2000) 1790-1800
30. Linker-Israeli M., Bakke A.C., Kitridou R.C., Gendler S., Gillis S., and Horwitz D.A. Defective production of interleukin 1 and 2 in patients with systemic lupus erythematosus (SLE). J. Immunol. 130 (1983) 2651-2655
31. Alcocer-Varela J., and Alarcon-Segovia D. Decreased production of and response to interleukin 2 by cultured lymphocytes from patients with systemic lupus erythematosus. J. Clin. Invest. 69 (1982) 1388-1392
32. Solomou E.E., Juang Y.T., Gourley M.F., Kammer G.M., and Tsokos G.C. Molecular basis of deficient IL-2 production in T cells from patients with systemic lupus erythematosus. J. Immunol. 166 (2001) 4216-4222
33. Tenbrock K., Juang Y.T., Gourley M.F., Nambiar M.P., and Tsokos G.C. Antisense cyclic adenosine 5′-monophosphate response element modulator up-regulates IL-2 in T cells from patients with systemic lupus erythematosus. J. Immunol. 169 (2002) 4147-4152
34. Segal R., Bermas B.L., Dayan M., Kalush F., Shearer G.M., and Mozes E. Kinetics of cytokine production in experimental systemic lupus erythematosus: involvement of T helper cell 1/T helper cell 2-type cytokines in disease. J. Immunol. 158 (1997) 3009-3016
35. Sun K.H., Tang S.J., Lin M.L., Wang Y.S., Sun G.H., and Liu W.T. Monoclonal antibodies against human ribosomal P proteins penetrate into living cells and cause apoptosis of Jurkat T cells in culture. Rheumatology 40 (2001) 750-756
36. Juang Y.T., Wang Y., Solomou E.E., Li Y., Mawrin C., Tenbrock K., Kyttaris V.C., and Tsokos G.C. Systemic lupus erythematosus serum IgG increases CREM binding to the IL-2 promoter and suppresses IL-2 production through CaMKIV. J. Clin. Invest. 115 (2005) 996-1005
37. Hamilton B.J., Nagy E., Malter J.S., Arrick B.A., and Rigby W.F. Association of heterogeneous nuclear ribonucleoprotein A1 and C proteins with reiterated AUUUA sequences. J. Biol. Chem. 268 (1993) 8881-8887
38. Henics T., Sanfridson A., Hamilton B.J., Nagy E., and Rigby W.F. Enhanced stability of interleukin-2 mRNA in MLA 144 cells. Possible role of cytoplasmic AU-rich sequence-binding proteins. J. Biol. Chem. 269 (1994) 5377-5383
39. Shetty S., Ganachari M., Liu M.-C., Azghani A., Muniyappa H., and Idell S. Regulation of urokinase receptor expression by phosphoglycerate kinase is independent of its catalytic activity. Am. J. Physiol.: Lung Cell. Mol. Physiol. 289 (2005) L591-L598